Skip to main content
Equibles

STATE STREET CORP

Position in CING — Cingulate Inc.

CIK 93751 BOSTON, MA
Back to CING Full portfolio

Position in CING

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$261,947
+$90,626 QoQ
Shares Held
47,888
+73.6% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in CING Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. CING ranks #340 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in CING

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $261,947 47,888
2026-03-31 $171,321 27,588
2023-09-30 $31,734 44,760
2023-06-30 $41,626 44,760
2023-03-31 $44,088 44,760